CompoAtlas

CARNATION CALLOUS CAPS

Natural health product licensed in Canada

Licence holder
Cuxson Gerrard & Company Limited
NPN or DIN-HM
02240322
Status
Active licence
Licence date
23 October 2009
Revision date
3 March 2014
Form
Plâtre
Route of administration
Topique
Application type
DIN de transition

Oral dose analysis does not apply without an established exclusively oral route.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the source
Acide 2-hydroxybenzoïque40 % (p/p)

Non-medicinal ingredients

C.I. Food yellow 3, Trisodium 1-(1-naphthylazo)-2-hydroxynaphthalene-4',6,8-trisulphonate, Caprylic/capric acid tryglyceride, Peanut Oil, Cire d'abeille jaune, Hydrogenated rosin

PopulationAgeQuantity per servingFrequency
Sous-population S/Ominimum: 16 years1 pansement adhésif48 hours

Uses authorised in Canada

Text supplied in English because no French text is available.

For the removal of callouses.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 02240322

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

List recorded in 2014. Photograph the packaging to check whether it has changed. Photograph the packaging

List recorded in 2014. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line